StockScan > Holders > Ra Capital Management

Ra Capital Management's Portfolio and 13F Filing

Value: $4.7B
Website:
CIK: 0001346824
Phone: 617-778-2500
Address: 200 Berkeley Street, 18th Floor, Boston, MA (02116)
Latest 13F Filing: 2026-08-14
Ra Capital Management's Stock Holdings & 13F Form
# Stock Name Symbol Current Price

Previous Holdings

(# Shares)

Current Holdings

(# Shares)

Current Value Percent
21 Taysha Gene Therapies, Inc. Common Stock TSHA $3.58 N/A 23,555,648 $84,329,220 1.79%
22 LB Pharmaceuticals Inc Common Stock LBRX $34.79 N/A 2,208,604 $76,837,333 1.63%
23 Solid Biosciences Inc. Common Stock SLDB $5.82 N/A 12,036,126 $70,050,253 1.49%
24 4D Molecular Therapeutics, Inc. Common Stock FDMT $12.36 N/A 5,049,779 $62,415,268 1.33%
25 Intellia Therapeutics, Inc NTLA $11.91 N/A 4,526,926 $53,915,689 1.15%
26 Definium Therapeutics, Inc. Common Shares DFTX $34.38 N/A 1,500,000 $51,570,000 1.10%
27 Geron Corp GERN $1.20 N/A 42,809,751 $51,371,701 1.09%
28 PepGen Inc. Common Stock PEPG $2.50 N/A 20,064,545 $50,161,363 1.07%
29 Jade Biosciences, Inc. Common Stock JBIO $13.42 N/A 3,671,083 $49,265,934 1.05%
30 Monopar Therapeutics Inc. Common Stock MNPR $72.08 N/A 667,207 $48,092,281 1.02%
31 Vor Biopharma Inc. Common Stock VOR $19.06 N/A 2,402,095 $45,783,931 0.97%
32 Sana Biotechnology, Inc. Common Stock SANA $2.41 N/A 18,750,000 $45,187,500 0.96%
33 Aclaris Therapeutics, Inc. ACRS $3.47 N/A 12,723,026 $44,148,900 0.94%
34 ARS Pharmaceuticals, Inc. Common Stock SPRY $4.05 N/A 10,860,977 $43,986,957 0.94%
35 Rezolute, Inc. Common Stock (NV) RZLT $4.61 N/A 9,445,039 $43,541,630 0.93%
36 Sionna Therapeutics, Inc. Common Stock SION $4.38 N/A 9,905,045 $43,384,097 0.92%
37 Acumen Pharmaceuticals, Inc. Common Stock ABOS $1.82 N/A 20,992,669 $38,101,694 0.81%
38 Mirum Pharmaceuticals, Inc. Common Stock MIRM $79.62 N/A 318,554 $25,363,269 0.54%
39 Century Therapeutics, Inc. Common Stock IPSC $1.38 N/A 17,754,430 $24,501,113 0.52%
40 Prelude Therapeutics Incorporated PRLD $3.56 N/A 6,475,882 $23,054,140 0.49%